Literature DB >> 21435451

Expression of prostaglandin E synthases in periodontitis immunolocalization and cellular regulation.

Tove Båge1, Anna Kats, Blanca Silva Lopez, Gareth Morgan, Gunnar Nilsson, Idil Burt, Marina Korotkova, Lisa Corbett, Alan J Knox, Leonardo Pino, Per-Johan Jakobsson, Thomas Modéer, Tülay Yucel-Lindberg.   

Abstract

The inflammatory mediator prostaglandin E(2) (PGE(2)) is implicated in the pathogenesis of chronic inflammatory diseases including periodontitis; it is synthesized by cyclooxygenases (COX) and the prostaglandin E synthases mPGES-1, mPGES-2, and cPGES. The distribution of PGES in gingival tissue of patients with periodontitis and the contribution of these enzymes to inflammation-induced PGE(2) synthesis in different cell types was investigated. In gingival biopsies, positive staining for PGES was observed in fibroblasts and endothelial, smooth muscle, epithelial, and immune cells. To further explore the contribution of PGES to inflammation-induced PGE(2) production, in vitro cell culture experiments were performed using fibroblasts and endothelial, smooth muscle, and mast cells. All cell types expressed PGES and COX-2, resulting in basal levels of PGE(2) synthesis. In response to tumor necrosis factor (TNF-α), IL-1β, and cocultured lymphocytes, however, mPGES-1 and COX-2 protein expression increased in fibroblasts and smooth muscle cells, accompanied by increased PGE(2), whereas mPGES-2 and cPGES were unaffected. In endothelial cells, TNF-α increased PGE(2) production only via COX-2 expression, whereas in mast cells the cytokines did not affect PGE(2) enzyme expression or PGE(2) production. Furthermore, PGE(2) production was diminished in gingival fibroblasts derived from mPGES-1 knockout mice, compared with wild-type fibroblasts. These results suggest that fibroblasts and smooth muscle cells are important sources of mPGES-1, which may contribute to increased PGE(2) production in the inflammatory condition periodontitis.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21435451      PMCID: PMC3078457          DOI: 10.1016/j.ajpath.2010.12.048

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  77 in total

1.  Mast cells in periodontal disease.

Authors:  M Günhan; H Bostanci; O Günhan; M Demiriz
Journal:  Ann Dent       Date:  1991

Review 2.  Periodontal diseases.

Authors:  Bruce L Pihlstrom; Bryan S Michalowicz; Newell W Johnson
Journal:  Lancet       Date:  2005-11-19       Impact factor: 79.321

3.  Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression.

Authors:  Rui Han; Shanli Tsui; Terry J Smith
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

4.  Two types of microsomal prostaglandin E synthase: glutathione-dependent and -independent prostaglandin E synthases.

Authors:  K Watanabe; K Kurihara; Y Tokunaga; O Hayaishi
Journal:  Biochem Biophys Res Commun       Date:  1997-06-09       Impact factor: 3.575

Review 5.  Modulation of host PGE2 secretion as a determinant of periodontal disease expression.

Authors:  S Offenbacher; P A Heasman; J G Collins
Journal:  J Periodontol       Date:  1993-05       Impact factor: 6.993

6.  Measurement of prostaglandin E2 and leukotriene B4 in the gingival crevicular fluid.

Authors:  C C Tsai; Y C Hong; C C Chen; Y M Wu
Journal:  J Dent       Date:  1998-03       Impact factor: 4.379

7.  Signal pathways JNK and NF-kappaB, identified by global gene expression profiling, are involved in regulation of TNFalpha-induced mPGES-1 and COX-2 expression in gingival fibroblasts.

Authors:  Tove Båge; Johan Lindberg; Joakim Lundeberg; Thomas Modéer; Tülay Yucel-Lindberg
Journal:  BMC Genomics       Date:  2010-04-15       Impact factor: 3.969

Review 8.  Fibroblasts as novel therapeutic targets in chronic inflammation.

Authors:  S J Flavell; T Z Hou; S Lax; A D Filer; M Salmon; C D Buckley
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

9.  Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium.

Authors:  M Westman; M Korotkova; E af Klint; A Stark; L P Audoly; L Klareskog; A-K Ulfgren; P-J Jakobsson
Journal:  Arthritis Rheum       Date:  2004-06

10.  Stem cell factor is a chemotactic factor for human mast cells.

Authors:  G Nilsson; J H Butterfield; K Nilsson; A Siegbahn
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

View more
  12 in total

1.  TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss.

Authors:  Srinivas R Myneni; Rajendra P Settem; Terry D Connell; Achsah D Keegan; Sarah L Gaffen; Ashu Sharma
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

2.  Electronic nicotine delivery system-induced alterations in oral health via saliva assessment.

Authors:  Saeed Alqahtani; Bruce Cooper; Claire A Spears; Christa Wright; Jonathan Shannahan
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-08

3.  Histamine modulates salivary secretion and diminishes the progression of periodontal disease in rat experimental periodontitis.

Authors:  Juan P Prestifilippo; Eliana Carabajal; Máximo Croci; Javier Fernández-Solari; Elena S Rivera; Juan C Elverdin; Vanina A Medina
Journal:  Inflamm Res       Date:  2012-01-20       Impact factor: 4.575

4.  Targeting microsomal prostaglandin E synthase 1 to develop drugs treating the inflammatory diseases.

Authors:  Qian Wang; Yuanyuan Li; Mengying Wu; Songming Huang; Aihua Zhang; Yue Zhang; Zhanjun Jia
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

5.  Decreased PGE₂ content reduces MMP-1 activity and consequently increases collagen density in human varicose vein.

Authors:  Ingrid Gomez; Chabha Benyahia; Liliane Louedec; Guy Leséche; Marie-Paule Jacob; Dan Longrois; Xavier Norel
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

6.  Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells.

Authors:  Anna Kats; Maria Norgård; Zenebech Wondimu; Catalin Koro; Hernán Concha Quezada; Göran Andersson; Tülay Yucel-Lindberg
Journal:  J Cell Mol Med       Date:  2016-03-14       Impact factor: 5.310

7.  Effects of theaflavins on tissue inflammation and bone resorption on experimental periodontitis in rats.

Authors:  Ya-Hsin Wu; Ryutaro Kuraji; Yuji Taya; Hiroshi Ito; Yukihiro Numabe
Journal:  J Periodontal Res       Date:  2018-08-30       Impact factor: 4.419

8.  Gene expression profiling of periodontitis-affected gingival tissue by spatial transcriptomics.

Authors:  Anna Lundmark; Natalija Gerasimcik; Tove Båge; Anders Jemt; Annelie Mollbrink; Fredrik Salmén; Joakim Lundeberg; Tülay Yucel-Lindberg
Journal:  Sci Rep       Date:  2018-06-19       Impact factor: 4.379

9.  Aminothiazoles inhibit osteoclastogenesis and PGE2 production in LPS-stimulated co-cultures of periodontal ligament and RAW 264.7 cells, and RANKL-mediated osteoclastogenesis and bone resorption in PBMCs.

Authors:  Anna Kats; Natalija Gerasimcik; Tuomas Näreoja; Jonas Nederberg; Simon Grenlöv; Ekaterina Lagnöhed; Suchita Desai; Göran Andersson; Tülay Yucel-Lindberg
Journal:  J Cell Mol Med       Date:  2018-12-01       Impact factor: 5.310

10.  Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo.

Authors:  Anna Kats; Tove Båge; Pierre Georgsson; Jörgen Jönsson; Hernán Concha Quezada; Anders Gustafsson; Leif Jansson; Claes Lindberg; Karin Näsström; Tülay Yucel-Lindberg
Journal:  FASEB J       Date:  2013-02-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.